Name | INVITRO, OOO |
|---|
INN | 6809025480 |
|---|
KPP | 680901001 |
|---|
OGRN | 1086809001069 |
|---|
OKPO | 87169064 |
|---|
Address | 393957, Tambovskaya Oblast', r-n Morshanskiy, s Ust'e, ul Rabochaya, d. STR. 1V |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 27.11.2008 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N7 po Tambovskoy oblasti |
|---|
|
INVITRO, OOO (Tambov Oblast; INN 6809025480) was registered on 27 Nov 2008. The company's authorized capital as of July 1, 2012 was 25000 rub. Type of ownership of INVITRO, OOO - Limited liability companies. Form of ownership of INVITRO, OOO - Private property. Principal activities of INVITRO, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of INVITRO, OOO grew over 2023 by 6.46% to 4.20 million RUB from 3.95 million RUB over 2022, the company informed. Revenue increased in the accounting period by 2.60% to 38.11 million RUB from 37.14 million RUB over 2022; cost of goods sold grew by 1.68% to 30.75 million RUB from 30.24 million RUB; sales profit went up by 5.89% to 4.98 million RUB from 4.71 million RUB. 2022
Net profit (RAS) of INVITRO, OOO grew over 2022 by 4.39% to 3.95 million RUB from 3.78 million RUB over 2021, the company informed. Revenue increased in the accounting period by 3.60% to 37.14 million RUB from 35.85 million RUB over 2021; cost of goods sold grew by 2.65% to 30.24 million RUB from 29.46 million RUB; sales profit went up by 4.02% to 4.71 million RUB from 4.52 million RUB. 2021
Net profit (RAS) of INVITRO, OOO grew over 2021 by 0.88% to 3.78 million RUB from 3.75 million RUB over 2020, the company informed. Revenue increased in the accounting period by 13.21% to 35.85 million RUB from 31.67 million RUB over 2020; cost of goods sold grew by 14.22% to 29.46 million RUB from 25.79 million RUB; sales profit went up by 12.82% to 4.52 million RUB from 4.01 million RUB. 2020
Net profit (RAS) of INVITRO, OOO grew over 2020 1.65 times to 3.75 million RUB from 2.27 million RUB over 2019, the company informed. Revenue increased in the accounting period by 23.73% to 31.67 million RUB from 25.59 million RUB over 2019; cost of goods sold grew by 23.08% to 25.79 million RUB from 20.95 million RUB; sales profit went up 1.71 times to 4.01 million RUB from 2.35 million RUB. 2019
Net profit (RAS) of INVITRO, OOO grew over 2019 by 7.13% to 2.27 million RUB from 2.12 million RUB over 2018, the company informed. Revenue increased in the accounting period by 26.52% to 25.59 million RUB from 20.23 million RUB over 2018; cost of goods sold grew by 28.04% to 20.95 million RUB from 16.37 million RUB; sales profit went up by 7.46% to 2.35 million RUB from 2.18 million RUB. 2018
Net profit (RAS) of INVITRO, OOO grew over 2018 by 3.16% to 2.12 million RUB from 2.05 million RUB over 2017, the company informed. Revenue remained in the accounting period at the same level and made up 20.23 million RUB compared to 20.13 million RUB 20.13 million RUB; cost of goods sold decreased by 2.82% to 16.37 million RUB from 16.84 million RUB; sales profit went up by 3.16% to 2.18 million RUB from 2.12 million RUB. 2017
Net profit (RAS) of INVITRO, OOO dropped in 2017 by 13.48% to 2.05 million RUB from 2.37 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 1.28% to 20.13 million RUB from 20.39 million RUB in 2016; cost of goods sold remained at the same level amounting to 16.84 million RUB compared to 16.80 million RUB; sales profit fell by 13.13% to 2.12 million RUB from 2.44 million RUB. 2016
Net profit (RAS) of INVITRO, OOO dropped in 2016 by 8.02% to 2.37 million RUB from 2.58 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 6.01% to 20.39 million RUB from 19.24 million RUB over 2015; cost of goods sold grew by 7.38% to 16.80 million RUB from 15.64 million RUB; sales profit fell by 7.83% to 2.44 million RUB from 2.64 million RUB. 2014
Net profit (RAS) of Invitro, OOO grew over 2014 by 18.34% to 1.78 million RUB from 1.51 million RUB over 2013, the company informed. Revenue increased in the accounting period by 15.58% to 15.48 million RUB from 13.39 million RUB over 2013; cost of goods sold grew by 16.27% to 12.81 million RUB from 11.02 million RUB; sales profit went up by 17.77% to 1.87 million RUB from 1.59 million RUB. 2013
Net profit (RAS) of Invitro, OOO dropped in 2013 by 16.80% to 1.51 million RUB from 1.81 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 11.50% to 13.39 million RUB from 15.13 million RUB in 2012; cost of goods sold decreased by 11.86% to 11.02 million RUB from 12.50 million RUB; sales profit fell by 15.90% to 1.59 million RUB from 1.89 million RUB. 2012
Net profit (RAS) of Invitro, OOO grew over 2012 by 3.02% to 1.81 million RUB from 1.76 million RUB over 2011, the company informed. Revenue decreased in the accounting period by 1.12% to 15.13 million RUB from 15.30 million RUB in 2011; cost of goods sold decreased by 1.71% to 13.24 million RUB from 13.47 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|